Photogen Buys Alliance’s Imagent To Build Cardiovascular Imaging Franchise
This article was originally published in The Gray Sheet
Executive Summary
Photogen Technologies' acquisition of Alliance Pharmaceutical's medical imaging assets provides a cardiovascular market entry at least three years ahead of the company's own internal R&D program